Jung‐Mi Hah

814 total citations
38 papers, 625 citations indexed

About

Jung‐Mi Hah is a scholar working on Molecular Biology, Computational Theory and Mathematics and Organic Chemistry. According to data from OpenAlex, Jung‐Mi Hah has authored 38 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 18 papers in Computational Theory and Mathematics and 13 papers in Organic Chemistry. Recurrent topics in Jung‐Mi Hah's work include Computational Drug Discovery Methods (18 papers), Melanoma and MAPK Pathways (17 papers) and Synthesis and biological activity (7 papers). Jung‐Mi Hah is often cited by papers focused on Computational Drug Discovery Methods (18 papers), Melanoma and MAPK Pathways (17 papers) and Synthesis and biological activity (7 papers). Jung‐Mi Hah collaborates with scholars based in South Korea, Pakistan and China. Jung‐Mi Hah's co-authors include Jaeyoon Chung, Jung-Hun Lee, Waqar Aman, Art E. Cho, Se‐Jin Lee, Young Soo Kim, Jiyoon Kim, Seungyeop Baek, Minjung Kim and Jisu Shin and has published in prestigious journals such as International Journal of Molecular Sciences, Journal of Medicinal Chemistry and Molecules.

In The Last Decade

Jung‐Mi Hah

37 papers receiving 614 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jung‐Mi Hah South Korea 14 316 203 150 129 89 38 625
Travis T. Denton United States 16 541 1.7× 194 1.0× 175 1.2× 55 0.4× 48 0.5× 45 1.1k
Eddine Saiah United States 21 468 1.5× 300 1.5× 83 0.6× 104 0.8× 101 1.1× 31 973
Alessandra Feoli Italy 15 401 1.3× 102 0.5× 87 0.6× 75 0.6× 117 1.3× 23 625
О.А. Бунеева Russia 18 610 1.9× 128 0.6× 108 0.7× 45 0.3× 81 0.9× 90 1.0k
Pedro Besada Spain 20 439 1.4× 388 1.9× 53 0.4× 90 0.7× 95 1.1× 50 964
Isak Im South Korea 12 295 0.9× 147 0.7× 99 0.7× 37 0.3× 44 0.5× 16 534
Stefania Baraldi Italy 18 398 1.3× 370 1.8× 67 0.4× 43 0.3× 116 1.3× 29 906
Lidia Ciccone Italy 18 484 1.5× 117 0.6× 178 1.2× 60 0.5× 103 1.2× 56 808
Jayalakshmi Sridhar United States 17 375 1.2× 177 0.9× 47 0.3× 158 1.2× 71 0.8× 34 874
Amy W. Veenhuizen United States 8 190 0.6× 375 1.8× 126 0.8× 69 0.5× 222 2.5× 10 723

Countries citing papers authored by Jung‐Mi Hah

Since Specialization
Citations

This map shows the geographic impact of Jung‐Mi Hah's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jung‐Mi Hah with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jung‐Mi Hah more than expected).

Fields of papers citing papers by Jung‐Mi Hah

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jung‐Mi Hah. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jung‐Mi Hah. The network helps show where Jung‐Mi Hah may publish in the future.

Co-authorship network of co-authors of Jung‐Mi Hah

This figure shows the co-authorship network connecting the top 25 collaborators of Jung‐Mi Hah. A scholar is included among the top collaborators of Jung‐Mi Hah based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jung‐Mi Hah. Jung‐Mi Hah is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kim, Hyejin, et al.. (2025). Targeting JNK3 for Alzheimer's disease: Design and synthesis of novel inhibitors with aryl group diversity utilizing wide pocket. European Journal of Medicinal Chemistry. 285. 117209–117209. 2 indexed citations
2.
Kim, Hyejin, et al.. (2024). Discovery of N-(5-amido-2-methylphenyl)-5-methylisoxazole-3-carboxamide as dual CSF-1R/c-Kit Inhibitors with improved stability and BBB permeability. European Journal of Medicinal Chemistry. 268. 116253–116253. 1 indexed citations
3.
Moon, Jihyun, et al.. (2024). Gaining Insights into Key Structural Hotspots within the Allosteric Binding Pockets of Protein Kinases. International Journal of Molecular Sciences. 25(9). 4725–4725. 1 indexed citations
4.
Hah, Jung‐Mi, et al.. (2023). An Intriguing Purview on the Design of Macrocyclic Inhibitors for Unexplored Protein Kinases through Their Binding Site Comparison. Pharmaceuticals. 16(7). 1009–1009. 6 indexed citations
5.
Kim, Hyejin, et al.. (2022). Novel 1,4,5,6-tetrahydrocyclopenta[d]imidazole-5-carboxamide-based JNK3 inhibitors: Design, synthesis, molecular docking, and therapeutic potential in neurodegenerative diseases. European Journal of Medicinal Chemistry. 245(Pt 1). 114917–114917. 10 indexed citations
6.
Hah, Jung‐Mi, et al.. (2021). Generation of Non-Nucleotide CD73 Inhibitors Using a Molecular Docking and 3D-QSAR Approach. International Journal of Molecular Sciences. 22(23). 12745–12745. 4 indexed citations
7.
Kim, Jinwoong, et al.. (2019). Computer-aided design and synthesis of 3-carbonyl-5-phenyl-1H-pyrazole as highly selective and potent BRAFV600E and CRAF inhibitor. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 1314–1320. 10 indexed citations
8.
Hah, Jung‐Mi, et al.. (2019). Conformational restriction of a type II FMS inhibitor leading to discovery of 5-methyl-N-(2-aryl-1H-benzo[d]imidazo-5-yl)isoxazole-4-carboxamide analogues as selective FLT3 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry. 34(1). 1716–1721. 7 indexed citations
9.
Kim, Jinwoong, et al.. (2019). Design, synthesis, and in vitro evaluation of N-(3-(3-alkyl-1H-pyrazol-5-yl) phenyl)-aryl amide for selective RAF inhibition. Bioorganic & Medicinal Chemistry Letters. 29(4). 534–538. 8 indexed citations
10.
Aman, Waqar, et al.. (2017). Novel scaffold evolution through combinatorial 3D-QSAR model studies of two types of JNK3 inhibitors. Bioorganic & Medicinal Chemistry Letters. 27(10). 2139–2143. 11 indexed citations
11.
Yang, Seung‐Hoon, Jisu Shin, Se‐Jin Lee, et al.. (2016). Nec‐1 alleviates cognitive impairment with reduction of Aβ and tau abnormalities in APP / PS 1 mice. EMBO Molecular Medicine. 9(1). 61–77. 134 indexed citations
12.
Aman, Waqar, et al.. (2016). Discovery of highly selective CRAF inhibitors, 3-carboxamido-2H-indazole-6-arylamide: In silico FBLD design, synthesis and evaluation. Bioorganic & Medicinal Chemistry Letters. 26(4). 1188–1192. 48 indexed citations
13.
Kim, Mi‐Hyun, Jung-Hun Lee, & Jung‐Mi Hah. (2015). De Novo Design and Synthesis of a γ‐Turn Peptidomimetic Scaffold and Its Application as JNK3 Allosteric Ligand. Chemistry - An Asian Journal. 10(6). 1318–1326. 4 indexed citations
14.
Kim, Mi‐Hyun, Jung-Hun Lee, Kyungjin Jung, et al.. (2013). Syntheses and biological evaluation of 1-heteroaryl-2-aryl-1H-benzimidazole derivatives as c-Jun N-terminal kinase inhibitors with neuroprotective effects. Bioorganic & Medicinal Chemistry. 21(8). 2271–2285. 38 indexed citations
15.
Li, Fei, Yunjeong Park, Jung‐Mi Hah, & Jae‐Sang Ryu. (2012). Synthesis and biological evaluation of 1-(6-methylpyridin-2-yl)-5-(quinoxalin-6-yl)-1,2,3-triazoles as transforming growth factor-β type 1 receptor kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 23(4). 1083–1086. 16 indexed citations
16.
Chung, Jaeyoon, Seung Joo Cho, Art E. Cho, & Jung‐Mi Hah. (2012). In silico binding free energy predictability with π–π interaction energy-augmented scoring function: Benzimidazole Raf inhibitors as a case study. Bioorganic & Medicinal Chemistry Letters. 22(9). 3278–3283. 3 indexed citations
17.
Chung, Jaeyoon, Seung Joo Cho, & Jung‐Mi Hah. (2011). A python-based docking program utilizing a receptor bound ligand shape: PythDock. Archives of Pharmacal Research. 34(9). 1451–1458. 7 indexed citations
18.
Kim, Hyangmi, et al.. (2011). Syntheses of phenylpyrazolodiazepin-7-ones as conformationally rigid analogs of aminopyrazole amide scaffold and their antiproliferative effects on cancer cells. Bioorganic & Medicinal Chemistry. 19(22). 6760–6767. 13 indexed citations
19.
Baek, Hyung Hee, So Young Kwon, Shin‐Joung Rho, et al.. (2011). Enhanced solubility and bioavailability of flurbiprofen by cycloamylose. Archives of Pharmacal Research. 34(3). 391–397. 26 indexed citations
20.
Chung, Jaeyoon, et al.. (2010). QM/MM based 3D QSAR models for potent B-Raf inhibitors. Journal of Computer-Aided Molecular Design. 24(5). 385–397. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Travis T. Denton Breakdown of academic impact, for papers by Eddine Saiah Breakdown of academic impact, for papers by Alessandra Feoli Breakdown of academic impact, for papers by О.А. Бунеева Breakdown of academic impact, for papers by Pedro Besada Breakdown of academic impact, for papers by Isak Im Breakdown of academic impact, for papers by Stefania Baraldi Breakdown of academic impact, for papers by Lidia Ciccone Breakdown of academic impact, for papers by Jayalakshmi Sridhar Breakdown of academic impact, for papers by Amy W. Veenhuizen
Rankless by CCL
2026